159 related articles for article (PubMed ID: 11129423)
21. The prognostic significance of overexpression of the decoy receptor for Fas ligand (DcR3) in patients with gastric carcinomas.
Takahama Y; Yamada Y; Emoto K; Fujimoto H; Takayama T; Ueno M; Uchida H; Hirao S; Mizuno T; Nakajima Y
Gastric Cancer; 2002; 5(2):61-8. PubMed ID: 12111580
[TBL] [Abstract][Full Text] [Related]
22. Apoptosis induced by preoperative oral 5'-DFUR administration in gastric adenocarcinoma and its mechanism of action.
Zhao WH; Wang SF; Ding W; Sheng JM; Ma ZM; Teng LS; Wang M; Wu FS; Luo B
World J Gastroenterol; 2006 Mar; 12(9):1356-61. PubMed ID: 16552801
[TBL] [Abstract][Full Text] [Related]
23. c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations.
Korkolopoulou P; Goudopoulou A; Voutsinas G; Thomas-Tsagli E; Kapralos P; Patsouris E; Saetta AA
Urology; 2004 Jun; 63(6):1198-204. PubMed ID: 15183989
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of expression of apoptotic signal proteins in gastric carcinoma tissue.
Zhao XH; Gu SZ; Tian HG; Quan P; Pan BR
World J Gastroenterol; 2005 Jul; 11(25):3846-9. PubMed ID: 15991280
[TBL] [Abstract][Full Text] [Related]
25. Localization of Fas and Fas ligand in bone marrow cells demonstrating myelodysplasia.
Kitagawa M; Yamaguchi S; Takahashi M; Tanizawa T; Hirokawa K; Kamiyama R
Leukemia; 1998 Apr; 12(4):486-92. PubMed ID: 9557605
[TBL] [Abstract][Full Text] [Related]
26. Fas ligand upregulation is an early event in colonic carcinogenesis.
Bennett MW; O'Connell J; Houston A; Kelly J; O'Sullivan GC; Collins JK; Shanahan F
J Clin Pathol; 2001 Aug; 54(8):598-604. PubMed ID: 11477113
[TBL] [Abstract][Full Text] [Related]
27. Possible involvement of Fas system in the induction of apoptosis in human astrocytic brain tumors.
Fujita H; Koji T; Kitagawa N; Tsutsumi K; Abe K; Kaminogo M; Shibata S
Cell Mol Neurobiol; 2002 Aug; 22(4):393-406. PubMed ID: 12507389
[TBL] [Abstract][Full Text] [Related]
28. Apoptosis of antigen-specific T lymphocytes upon the engagement of CD8 by soluble HLA class I molecules is Fas ligand/Fas mediated: evidence for the involvement of p56lck, calcium calmodulin kinase II, and Calcium-independent protein kinase C signaling pathways and for NF-kappaB and NF-AT nuclear translocation.
Contini P; Ghio M; Merlo A; Poggi A; Indiveri F; Puppo F
J Immunol; 2005 Dec; 175(11):7244-54. PubMed ID: 16301629
[TBL] [Abstract][Full Text] [Related]
29. Fas ligand expression and its correlation with apoptosis and proliferation in Lobund-Wistar prostate carcinomas.
Gutierrez LS; Noria F; Finol H; Sun L; Castellino F; Pollard M
Pathobiology; 2005; 72(5):260-8. PubMed ID: 16374070
[TBL] [Abstract][Full Text] [Related]
30. Effects of FasL expression in oral squamous cell cancer.
Fang L; Sun L; Hu FF; Chen QE
Asian Pac J Cancer Prev; 2013; 14(1):281-5. PubMed ID: 23534738
[TBL] [Abstract][Full Text] [Related]
31. Fas ligand expression is correlated with metastasis in colorectal carcinoma.
Nozoe T; Yasuda M; Honda M; Inutsuka S; Korenaga D
Oncology; 2003; 65(1):83-8. PubMed ID: 12837986
[TBL] [Abstract][Full Text] [Related]
32. Expression and regulation of Fas and Fas ligand on thyrocytes and infiltrating cells during induction and resolution of granulomatous experimental autoimmune thyroiditis.
Wei Y; Chen K; Sharp GC; Yagita H; Braley-Mullen H
J Immunol; 2001 Dec; 167(11):6678-86. PubMed ID: 11714840
[TBL] [Abstract][Full Text] [Related]
33. Prognostic relevance of Fas (APO-1/CD95) ligand in human colorectal cancer.
Sheehan KM; O'Donovan DG; Fitzmaurice G; O'Grady A; O'Donoghue DP; Sheahan K; Byrne MF; Conroy RM; Kay EW; Murray FE
Eur J Gastroenterol Hepatol; 2003 Apr; 15(4):375-80. PubMed ID: 12655257
[TBL] [Abstract][Full Text] [Related]
34. Frequent expression of soluble Fas and Fas ligand in Chinese stomach cancer and its preneoplastic lesions.
Li H; Liu N; Guo L; Li JW; Liu J
Int J Mol Med; 2000 May; 5(5):473-6. PubMed ID: 10762649
[TBL] [Abstract][Full Text] [Related]
35. Fas ligand expressed in colon cancer is not associated with increased apoptosis of tumor cells in vivo.
Houston A; Waldron-Lynch FD; Bennett MW; Roche D; O'Sullivan GC; Shanahan F; O'Connell J
Int J Cancer; 2003 Nov; 107(2):209-14. PubMed ID: 12949796
[TBL] [Abstract][Full Text] [Related]
36. Expression of fas/fas ligand (fasL) and its involvement in infiltrating lymphocytes in hepatocellular carcinoma (HCC).
Fukuzawa Y; Takahashi K; Furuta K; Tagaya T; Ishikawa T; Wada K; Omoto Y; Koji T; Kakumu S
J Gastroenterol; 2001 Oct; 36(10):681-8. PubMed ID: 11686478
[TBL] [Abstract][Full Text] [Related]
37. The extrinsic apoptotic signaling pathway in gastric adenocarcinomas assessed by tissue microarray.
Gomes TS; Oshima CT; Segreto HR; Barrazueta LM; Costa HO; Lima FO; Forones NM; Ribeiro DA
Pathol Res Pract; 2011 Oct; 207(10):613-7. PubMed ID: 21856093
[TBL] [Abstract][Full Text] [Related]
38. Altered expression of FAS system is related to adverse clinical outcome in stage I-II breast cancer patients treated with adjuvant anthracycline-based chemotherapy.
Botti C; Buglioni S; Benevolo M; Giannarelli D; Papaldo P; Cognetti F; Vici P; Di Filippo F; Del Nonno F; Venanzi FM; Natali PG; Mottolese M
Clin Cancer Res; 2004 Feb; 10(4):1360-5. PubMed ID: 14977837
[TBL] [Abstract][Full Text] [Related]
39. Inducible nitric oxide synthase, nitrotyrosine and apoptosis in gastric adenocarcinomas and their correlation with a poor survival.
Li LG; Xu HM
World J Gastroenterol; 2005 May; 11(17):2539-44. PubMed ID: 15849807
[TBL] [Abstract][Full Text] [Related]
40. Fas and Fas-ligand expression in human pancreatic cancer.
Kornmann M; Ishiwata T; Kleeff J; Beger HG; Korc M
Ann Surg; 2000 Mar; 231(3):368-79. PubMed ID: 10714630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
